Literature DB >> 27694707

Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors.

Stephanie A Harmon1, Michael J Tuite, Robert Jeraj.   

Abstract

Site selection for image-guided biopsies in patients with multiple lesions is typically based on clinical feasibility and physician preference. This study outlines the development of a selection algorithm that, in addition to clinical requirements, incorporates quantitative imaging data for automatic identification of candidate lesions for biopsy. The algorithm is designed to rank potential targets by maximizing a lesion-specific score, incorporating various criteria separated into two categories: (1) physician-feasibility category including physician-preferred lesion location and absolute volume scores, and (2) imaging-based category including various modality and application-specific metrics. This platform was benchmarked in two clinical scenarios, a pre-treatment setting and response-based setting using imaging from metastatic prostate cancer patients with high disease burden (multiple lesions) undergoing conventional treatment and receiving whole-body [18F]NaF PET/CT scans pre- and mid-treatment. Targeting of metastatic lesions was robust to different weighting ratios and candidacy for biopsy was physician confirmed. Lesion ranked as top targets for biopsy remained so for all patients in pre-treatment and post-treatment biopsy selection after sensitivity testing was completed for physician-biased or imaging-biased scenarios. After identifying candidates, biopsy feasibility was evaluated by a physician and confirmed for 90% (32/36) of high-ranking lesions, of which all top choices were confirmed. The remaining cases represented lesions with high anatomical difficulty for targeting, such as proximity to sciatic nerve. This newly developed selection method was successfully used to quantitatively identify candidate lesions for biopsies in patients with multiple lesions. In a prospective study, we were able to successfully plan, develop, and implement this technique for the selection of a pre-treatment biopsy location.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27694707      PMCID: PMC5288736          DOI: 10.1088/0031-9155/61/20/7282

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  57 in total

1.  Where can FDG-PET contribute most to anatomical imaging problems?

Authors:  John B Bingham
Journal:  Br J Radiol       Date:  2002-11       Impact factor: 3.039

2.  The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.

Authors:  Karen A Kurdziel; Joanna H Shih; Andrea B Apolo; Liza Lindenberg; Esther Mena; Yolanda Y McKinney; Stephen S Adler; Baris Turkbey; William Dahut; James L Gulley; Ravi A Madan; Ola Landgren; Peter L Choyke
Journal:  J Nucl Med       Date:  2012-06-22       Impact factor: 10.057

3.  Percutaneous CT-guided biopsy of osseous lesion of the spine in patients with known or suspected malignancy.

Authors:  Eric Lis; Mark H Bilsky; Leszek Pisinski; Patrick Boland; John H Healey; Bernie O'malley; George Krol
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

4.  Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.

Authors:  Charles E Spritzer; P Diana Afonso; Emily N Vinson; James D Turnbull; Karla K Morris; Adam Foye; John F Madden; Kingshuk Roy Choudhury; Phillip G Febbo; Daniel J George
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

5.  Image-guided biopsy: what the interventional radiologist needs to know about PET/CT.

Authors:  Katsuhiro Kobayashi; Peeyush Bhargava; Shanker Raja; Farbod Nasseri; Hassan A Al-Balas; Darryl D Smith; Sharad P George; Meena S Vij
Journal:  Radiographics       Date:  2012 Sep-Oct       Impact factor: 5.333

6.  PET/CT-guided percutaneous biopsy of abdominal masses: initial experience.

Authors:  Servet Tatli; Victor H Gerbaudo; Christina M Feeley; Paul B Shyn; Kemal Tuncali; Stuart G Silverman
Journal:  J Vasc Interv Radiol       Date:  2011-03-02       Impact factor: 3.464

7.  CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.

Authors:  Yuji Nakamoto; Christian Cohade; Mitsuaki Tatsumi; Dima Hammoud; Richard L Wahl
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

Review 8.  Opportunities and pitfalls of cancer imaging in clinical trials.

Authors:  Bruno Morgan
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

9.  Tumor heterogeneity and drug resistance.

Authors:  D L Dexter; J T Leith
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

10.  [Discrepancies between primary tumor and metastasis: impact on personalized medicine].

Authors:  Stéphane Vignot; Jean-Charles Soria
Journal:  Bull Cancer       Date:  2013-06       Impact factor: 1.276

View more
  1 in total

Review 1.  Role of Image-Guided Percutaneous Needle Biopsy in the Age of Precision Medicine.

Authors:  Miyuki Sone; Shunsuke Sugawara; Yasushi Yatabe
Journal:  Curr Oncol Rep       Date:  2022-04-01       Impact factor: 5.945

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.